These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 6970370)

  • 1. The use of colour vision measurement in the diagnosis of digoxin toxicity.
    Aronson JK; Ford AR
    Q J Med; 1980; 49(195):273-82. PubMed ID: 6970370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Disorders of color perception in subtoxic and toxic digoxin and serum digoxin concentrations].
    Duncker G; Horst HA; Kolenda KD; Schenck F
    Klin Monbl Augenheilkd; 1988 Dec; 193(6):622-6. PubMed ID: 3265458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Color vision deficiencies: a common sign of intoxication in chronically digoxin-treated patients.
    Rietbrock N; Alken RG
    J Cardiovasc Pharmacol; 1980; 2(1):93-9. PubMed ID: 6154209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Color perception disorders in therapeutic glycoside serum concentrations].
    Duncker G; Horst H; Kolenda KD; Schenck F
    Fortschr Med; 1983 Nov; 101(43):1970-3. PubMed ID: 6654298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Color vision testing to assist in diagnosis of digoxin toxicity.
    LeSage J
    Nurs Res; 1984; 33(6):346-51. PubMed ID: 6333672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnesium status and digoxin toxicity.
    Young IS; Goh EM; McKillop UH; Stanford CF; Nicholls DP; Trimble ER
    Br J Clin Pharmacol; 1991 Dec; 32(6):717-21. PubMed ID: 1768564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Technical note: the effect of refractive blur on colour vision evaluated using the Cambridge Colour Test, the Ishihara Pseudoisochromatic Plates and the Farnsworth Munsell 100 Hue Test.
    Thyagarajan S; Moradi P; Membrey L; Alistair D; Laidlaw H
    Ophthalmic Physiol Opt; 2007 May; 27(3):315-9. PubMed ID: 17470246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colour vision defects in occupational chronic solvent encephalopathy.
    Päällysaho J; Näsänen R; Mäntyjärvi M; Kaukiainen A; Sainio M
    Hum Exp Toxicol; 2007 Apr; 26(4):375-83. PubMed ID: 17615120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquired colour vision deficiency in patients receiving digoxin maintenance therapy.
    Lawrenson JG; Kelly C; Lawrenson AL; Birch J
    Br J Ophthalmol; 2002 Nov; 86(11):1259-61. PubMed ID: 12386084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ocular adverse effects to the therapeutic administration of digoxin.
    Hobley A; Lawrenson J
    Ophthalmic Physiol Opt; 1991 Oct; 11(4):391-3. PubMed ID: 1771077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Incidence and extent of digitalis-induced disorders of color vision. A comparative study of subtoxic and toxic digoxin and digitoxin serum concentrations].
    Horst HA; Kolenda KD; Duncker G; Schenck F; Löffler H
    Med Klin (Munich); 1988 Sep; 83(17):541-7. PubMed ID: 3262815
    [No Abstract]   [Full Text] [Related]  

  • 12. An averaging method for the interpretation of the Farnsworth-Munsell 100-Hue Test--II. Colour vision defects acquired in diabetic retinopathy.
    Birch J; Dain SJ
    Ophthalmic Physiol Opt; 1987; 7(3):281-91. PubMed ID: 3500447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using clinical tests of colour vision to predict the ability of colour vision deficient patients to name surface colours.
    Cole BL; Lian KY; Lakkis C
    Ophthalmic Physiol Opt; 2007 Jul; 27(4):381-8. PubMed ID: 17584289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An averaging method for the interpretation of the Farnsworth-Munsell 100-Hue Test--I. Congenital colour vision defects.
    Dain SJ; Birch J
    Ophthalmic Physiol Opt; 1987; 7(3):267-80. PubMed ID: 3500446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of colour difference vectors in diagnosing congenital colour vision deficiencies with the Farnsworth-Munsell 100-hue test.
    Vingrys AJ; Atchison DA; Bowman KJ
    Ophthalmic Physiol Opt; 1992 Jan; 12(1):38-45. PubMed ID: 1584615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tilted disc syndrome and colour vision.
    Vuori ML; Mäntyjärvi M
    Acta Ophthalmol Scand; 2007 Sep; 85(6):648-52. PubMed ID: 17403021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Digitalis intoxication: specifity and significance of cardiac and extracardiac symptoms. part II. Patients with extracardiac symptoms of digitalis intoxications (author's transl)].
    Doering W; König E; Sturm W
    Z Kardiol; 1977 Mar; 66(3):129-37. PubMed ID: 857453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Introducing a new computer-based test for the clinical evaluation of color discrimination.
    Melamud A; Simpson E; Traboulsi EI
    Am J Ophthalmol; 2006 Dec; 142(6):953-60. PubMed ID: 17157581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement in colour vision parameters following successful trabeculectomy.
    Magacho L; Henderer JD; Lankaranian D; Steinmann WC; Spaeth GL
    Acta Ophthalmol Scand; 2006 Apr; 84(2):201-5. PubMed ID: 16637837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency of colour vision deficiencies in melanoma patients: results of a prospective comparative screening study with the Farnsworth panel D 15 test including 300 melanoma patients and 100 healthy controls.
    Pföhler C; Tschöp S; König J; Rass K; Tilgen W
    Melanoma Res; 2006 Oct; 16(5):413-21. PubMed ID: 17013090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.